Zantac or ranitidine hydrochloride is an over-the-counter medication used to treat stomach acidity (by blocking histamine receptors in the stomach), heartburn, as well as gastric and duodenal ulcers. It has been in the market since the 1980s, with doses that range from 75 to 150 mg per tablet.
In September of 2019, however, a Connecticut-based pharmacy named Valisure, alerted the U.S. Food and Drug Administration that it had found NDMA, a cancer-causing chemical, in samples of Zantac and ranitidine. The FDA then confirmed that they were able to discover carcinogenic contaminants in Zantac on September 13, 2019. Their examination revealed that the popular heartburn medication had an NDMA concentration of up to 300 times higher than the daily recommended limit level by the FDA. The exposé would later result in the Zantac cancer lawsuit, with the affected persons filing cases in court for compensation.
After the FDA revealed Zantac’s potential to cause cancer, many global retailers took the medication off their shelves. Sanofi, a Zantac manufacturer, recalled the medication in the United States, Canada, and the U.K. On the other hand, Teva Pharmaceuticals and GlaxoSmithKline or GSK, which are some of the biggest drugmakers in the world, also recalled ranitidine. Since then, several countries have either sanctioned or halted the sale of ranitidine. Other countries have even issued warnings and launched their independent investigations following the initial recall of Zantac. Some of the types of cancer that are associated with Zantac use include:
- Bladder cancer
- Colorectal cancer (colon and rectal cancer)
- Intestinal cancer
- Esophageal cancer
- Kidney cancer
- Liver cancer
- Lung cancer (non-smokers)
- Ovarian cancer
Zantac Cancer Lawsuit
Numerous people who had contracted cancer after taking Zantac later turned to courts to file a Zantac cancer lawsuit, which holds Zantac brand companies, like Sanofi and Boehringer Ingelheim, responsible for completely disregarding human health in their quest to gain profits.
The primary claim of the lawsuit is that Sanofi, Boehringer, and other defendants failed to warn people about the side effects of the drug. The lawsuit further argues that ranitidine was unstable, and could easily form NDMA when it gets in contact with stomach conditions or nitrate elements that are commonly found in grilled meat and preserved food, such as hotdogs and bacon. The Zantac lawsuit demanded compensation for those who have ended up developing cancer as a result of the use of this drug.
Recently, the United States Judicial Panel on Multidistrict Litigation has merged lawsuits under U.S. District Judge Robin Rosenberg in the southern district of Florida. The panel is said to have indicated that the antacid drug case has the potential to be extensive litigation, with over 140 lawsuits already filed pending determination in the newly formed MDL No. 2924.
Joining the Zantac Lawsuit
Due to the Zantac medical malpractice, attorneys have been accepting claims. But for you to be able to join in the Zantac lawsuit it is a requirement that you meet the following conditions:
- You have proof that you have taken Zantac – as a claimant you have to prove that you used Zantac or any ranitidine medication. This can be shown through medical records, receipts and doctor’s notes.
- Confirm a cancer-related diagnosis – any potential claimant must confirm that they have been diagnosed with a cancer-related diagnosis that is linked to NDMA such as colorectal, bladder or esophageal cancer
It is important to note that only lawyers will be able to effectively evaluate a claim through gathered medical records and other pieces of evidence.
Types of Zantac Lawsuits
- Zantac Class actions Lawsuit:
Lawyers have been filing several Zantac Class actions on behalf of the residents of Florida, Connecticut, Massachusetts, New Jersey, and California. The class-action allows anyone who happened to have bought the antacid to get refunds for their spending. The argument is based on the fact that the manufacturer was ignorant of their failure to warn the public about the risks of NDMA cancer.
In the Zantac lawsuit, we have Zantac’s personal injury and Zantac’s wrongful death lawsuits. Both should be filed in the court by persons who developed cancer after taking the drug. The Zantac lawsuit enables affected individuals and families to gain necessary compensation for their injuries. Despite the variation in law from state to state, it is essential to know that the law will still allow you to receive compensation for medical bills, lost wages, pain, and suffering as well as the loss of past and future earnings.
Since Zantac or ranitidine hydrochloride has been proven by the U.S. Food and Drug Administration to have cancer-causing chemicals, a number of countries and drug-making companies have recalled the product to prevent the public from further exposure to the cancer element.